SunOpta (NASDAQ:STKL) Downgraded by StockNews.com

SunOpta (NASDAQ:STKL) (TSE:SOY) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Thursday.

SunOpta Stock Down 1.2 %

STKL opened at $6.67 on Thursday. The company has a quick ratio of 0.61, a current ratio of 1.27 and a debt-to-equity ratio of 1.67. The stock has a market cap of $796.60 million, a price-to-earnings ratio of -4.39 and a beta of 1.82. SunOpta has a twelve month low of $2.79 and a twelve month high of $7.59. The company’s 50-day moving average price is $5.84 and its two-hundred day moving average price is $5.94.

SunOpta (NASDAQ:STKL) (TSE:SOY) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.02 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.01 by $0.01. The company had revenue of $171.00 million during the quarter, compared to analysts’ expectations of $159.95 million. SunOpta had a negative net margin of 23.23% and a positive return on equity of 6.51%. The firm’s revenue was down 17.7% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.03) EPS. As a group, equities analysts expect that SunOpta will post 0.14 earnings per share for the current year.

Institutional Trading of SunOpta

Several institutional investors have recently bought and sold shares of STKL. Principal Financial Group Inc. boosted its stake in shares of SunOpta by 18.2% in the 1st quarter. Principal Financial Group Inc. now owns 12,425 shares of the company’s stock worth $85,000 after buying an additional 1,917 shares during the last quarter. Mackenzie Financial Corp lifted its holdings in SunOpta by 0.9% during the 2nd quarter. Mackenzie Financial Corp now owns 254,678 shares of the company’s stock valued at $1,370,000 after buying an additional 2,155 shares in the last quarter. Price T Rowe Associates Inc. MD grew its position in shares of SunOpta by 13.4% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,913 shares of the company’s stock worth $185,000 after buying an additional 3,171 shares in the last quarter. The Manufacturers Life Insurance Company increased its holdings in SunOpta by 10.5% during the second quarter. The Manufacturers Life Insurance Company now owns 36,958 shares of the company’s stock valued at $200,000 after buying an additional 3,521 shares during the period. Finally, Epiq Partners LLC raised its holdings in SunOpta by 1.3% in the first quarter. Epiq Partners LLC now owns 295,455 shares of the company’s stock worth $2,030,000 after purchasing an additional 3,750 shares in the last quarter. 85.39% of the stock is owned by hedge funds and other institutional investors.

SunOpta Company Profile

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.